CreativeOne Wealth LLC Grows Stake in Option Care Health, Inc. (NASDAQ:OPCH)

CreativeOne Wealth LLC raised its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 89.3% during the fourth quarter, HoldingsChannel.com reports. The fund owned 27,223 shares of the company’s stock after purchasing an additional 12,843 shares during the quarter. CreativeOne Wealth LLC’s holdings in Option Care Health were worth $632,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp purchased a new stake in shares of Option Care Health during the 4th quarter valued at about $26,000. UMB Bank n.a. boosted its stake in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after purchasing an additional 346 shares during the period. Signaturefd LLC grew its stake in Option Care Health by 487.9% in the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after acquiring an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC increased its holdings in Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock worth $40,000 after purchasing an additional 1,099 shares during the period. Finally, Sterling Capital Management LLC increased its stake in shares of Option Care Health by 638.5% during the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company’s stock valued at $69,000 after buying an additional 2,554 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on OPCH. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the company from $26.00 to $33.00 in a report on Monday, January 13th. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. JPMorgan Chase & Co. lifted their target price on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and upped their price target for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, Barrington Research upped their price objective on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Option Care Health currently has an average rating of “Moderate Buy” and an average price target of $33.00.

Option Care Health Stock Down 0.6 %

Shares of OPCH opened at $32.09 on Friday. The stock has a 50 day moving average price of $33.33 and a 200 day moving average price of $28.66. The stock has a market capitalization of $5.27 billion, a price-to-earnings ratio of 26.96, a PEG ratio of 2.30 and a beta of 1.07. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.64% of the stock is currently owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.